Cold Chain Focus CHINA
The nature and the high value of the bio/pharmaceutical temperature controlled supply chain makes managing this very challenging and expensive process. China is at the point of becoming the largest biotechnology/pharmaceutical market globally but the country is still far from developing a comprehensive and efficient cold chain distribution system for bio/ pharmaceutical products and clinical trial supplies. Also, the environmental, structural and regulatory obstacles are also massive for bio/pharma companies in China.
Learn how China is meeting the challenges of Cold Chain in this resource centre